Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silence Therapeutics (SLN) Operating Leases (2023 - 2025)

Silence Therapeutics' Operating Leases history spans 2 years, with the latest figure at $71000.0 for Q4 2025.

  • For Q4 2025, Operating Leases changed N/A year-over-year to $71000.0; the TTM value through Dec 2025 reached $71000.0, changed N/A, while the annual FY2025 figure was $71000.0, N/A changed from the prior year.
  • Operating Leases for Q4 2025 was $71000.0 at Silence Therapeutics, down from $97000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $115427.1 in Q4 2023 and bottomed at $71000.0 in Q4 2025.